Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. (Q40633414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Eileen M Boyle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Christopher P Wardell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Charlotte Pawlyn

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Annamaria Brioli

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ana Quartilho

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G. C. Cook

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Gareth J Morgan

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Alex Murison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Dil B Begum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Nasrin M Dahir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Paula Z Proszek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David C Johnson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Martin F Kaiser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lorenzo Melchor

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lauren I Aronson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Matthew Scales

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Fabio Mirabella

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

John R Jones

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Aneta Mikulasova

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Walter M Gregory

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Mark T Drayson

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Nigel Russell

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Graham H Jackson

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xavier Leleu

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Faith E Davies

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David A Cairns

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

17 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

3911-3920

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

Clinical and biologic implications of recurrent genomic aberrations in myeloma

22 February 2020

cites work

1 reference

12 December 2020

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma

1 reference

12 December 2020

International staging system for multiple myeloma

1 reference

12 December 2020

Global analysis of uniparental disomy using high density genotyping arrays

1 reference

12 December 2020

Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

1 reference

12 December 2020

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

1 reference

12 December 2020

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

1 reference

12 December 2020

A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.

1 reference

12 December 2020

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

1 reference

12 December 2020

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

1 reference

12 December 2020

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

1 reference

12 December 2020

Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients.

1 reference

12 December 2020

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes

1 reference

12 December 2020

Prognostic significance of copy-number alterations in multiple myeloma

1 reference

12 December 2020

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma

1 reference

12 December 2020

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

1 reference

12 December 2020

Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia

1 reference

12 December 2020

Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism

1 reference

12 December 2020

Initial genome sequencing and analysis of multiple myeloma

1 reference

12 December 2020

Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone

1 reference

12 December 2020

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

1 reference

12 December 2020

ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

1 reference

12 December 2020

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression

1 reference

12 December 2020

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data

1 reference

12 December 2020

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

1 reference

12 December 2020

A modified method for whole exome resequencing from minimal amounts of starting DNA

1 reference

12 December 2020

The genetic architecture of multiple myeloma.

1 reference

12 December 2020

A default Bayesian hypothesis test for correlations and partial correlations

1 reference

12 December 2020

DELLY: structural variant discovery by integrated paired-end and split-read analysis

1 reference

12 December 2020

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

1 reference

12 December 2020

A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR.

1 reference

12 December 2020

Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.

1 reference

12 December 2020

Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma

1 reference

12 December 2020

Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy

1 reference

12 December 2020

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

1 reference

12 December 2020

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

1 reference

12 December 2020

ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state

1 reference

12 December 2020

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

1 reference

12 December 2020

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer

1 reference

12 December 2020

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

1 reference

12 December 2020

MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib

1 reference

12 December 2020

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2014.59.1503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

Altmetric DOI

10.1200/JCO.2014.59.1503

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26282654%20AND%20SRC:MED&resulttype=core&format=json